The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Convulsive Therapy

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Convulsive Therapy


Psychiatry related information on Convulsive Therapy


High impact information on Convulsive Therapy

  • Shock therapy was associated with mild elevations of creatine phosphokinase MB (31 +/- 18 units), but there was no hemodynamic evidence of tricuspid insufficiency [3].
  • Insulin coma and various types of convulsive therapies were the major biologic treatment modalities in psychiatry before the psychopharmacological era [4].
  • The purpose of this study was to determine the ability of this VF confirmation algorithm to recognize nonsustained VT, and to analyze the reasons for failure of the PCD device to abort shock therapy for nonsustained VT despite use of this VF confirmation algorithm [5].
  • Cardiazol convulsive therapy, first used in Australia in 1937, appears to have been widely employed [6].
  • AD6, a coumarin derivative, and other pharmacological approaches to splanchnic artery occlusion (SAO) shock therapy [7].

Chemical compound and disease context of Convulsive Therapy


Gene context of Convulsive Therapy


  1. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Wathen, M.S., DeGroot, P.J., Sweeney, M.O., Stark, A.J., Otterness, M.F., Adkisson, W.O., Canby, R.C., Khalighi, K., Machado, C., Rubenstein, D.S., Volosin, K.J. Circulation (2004) [Pubmed]
  2. A review of evidence for GABergic predominance/glutamatergic deficit as a common etiological factor in both schizophrenia and affective psychoses: more support for a continuum hypothesis of "functional" psychosis. Squires, R.F., Saederup, E. Neurochem. Res. (1991) [Pubmed]
  3. Catheter-induced ablation of the atrioventricular junction to control refractory supraventricular arrhythmias. Scheinman, M.M., Morady, F., Hess, D.S., Gonzalez, R. JAMA (1982) [Pubmed]
  4. Atropine coma: a historical note. Gazdag, G., Bitter, I., Ungvári, G., Gerevich, J. The journal of ECT. (2005) [Pubmed]
  5. Failure of third-generation implantable cardioverter defibrillators to abort shock therapy for nonsustained ventricular tachycardia due to shortcomings of the VF confirmation algorithm. Grimm, W., Menz, V., Hoffmann, J., Maisch, B. Pacing and clinical electrophysiology : PACE. (1998) [Pubmed]
  6. The early history of convulsive therapies in Australia. Mitchell, P.B., Sengoz, A. Med. J. Aust. (1995) [Pubmed]
  7. AD6, a coumarin derivative, and other pharmacological approaches to splanchnic artery occlusion (SAO) shock therapy. Squadrito, F., Sturniolo, R., Altavilla, D., Caputi, A.P. Journal of chemotherapy (Florence, Italy) (1989) [Pubmed]
  8. Clinical and neuropathological aspects of long-term damage to the central nervous system after lithium medication. Peiffer, J. Archiv für Psychiatrie und Nervenkrankheiten. (1981) [Pubmed]
  9. New approaches to shock therapy: reduced glutathione (GSH). Kosugi, I., Tajimi, K., Ohmura, A., Okada, K. Prog. Clin. Biol. Res. (1983) [Pubmed]
  10. Comparison of thiopentone sodium and propofol for electro convulsive therapy (ECT). Zaidi, N.A., Khan, F.A. JPMA. The Journal of the Pakistan Medical Association. (2000) [Pubmed]
  11. Anaphylactic reaction to oral prednisone: a case report and review of the literature. Polosa, R., Cacciola, R., Pacino, G., Prosperini, G. Ann. Ital. Med. Int. (1998) [Pubmed]
  12. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Sweeney, M.O., Wathen, M.S., Volosin, K., Abdalla, I., DeGroot, P.J., Otterness, M.F., Stark, A.J. Circulation (2005) [Pubmed]
  13. Antioxidant drugs and shock therapy. Ortolani, O., Biasiucci, M., Trebbi, A., Cianciulli, M., Cuocolo, R. Prog. Clin. Biol. Res. (1987) [Pubmed]
WikiGenes - Universities